NCT06100471 (niEndometriosi) is a clinical trial of Observational study in Endometriosis, sponsored by Eurofins Genoma.

Who is sponsoring NCT06100471?

NCT06100471 is sponsored by Eurofins Genoma.

What drugs are being tested in NCT06100471?

Interventions in NCT06100471: Observational study.

What condition does NCT06100471 study?

NCT06100471 studies Endometriosis, Hypofertility.

Is NCT06100471 still recruiting?

NCT06100471 is currently status unknown. Last updated 20 February 2024.

Last reviewed 2024-02-20 · How we verify

NCT06100471: niEndometriosi

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Genetic Signature in Endometriosis Disease by Non Invasive Sampling

Status unknown Last updated 20 February 2024

What this trial tests

trial testing Observational study in Endometriosis in 150 participants. Status unknown.

Timeline

1 May 2023

Primary endpoint
31 July 2024

31 December 2024

Quick facts

Lead sponsor	Eurofins Genoma
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	1 May 2023
Primary completion	31 July 2024
Estimated completion	31 December 2024
Sites	1 location across Italy

Drugs / interventions tested

Observational study — full drug profile →

Conditions studied

Endometriosis — all drugs for Endometriosis →
Hypofertility — all drugs for Hypofertility →

Sponsor

Eurofins Genoma

Who can join

Adults 18 to 45, female only, with Endometriosis or Hypofertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Endometriosis is a disease that affects 10-15% of the general population and 50% of infertile women. It is characterized by the presence of endometrial tissue outside the uterine cavity. Endometriosis can lead to infertility by interfering through endocrine and mechanical alterations on the function of the ovaries, fallopian tubes, and uterus. The aim of the study is to define the differential expression of a cluster of RNAs tissue driven for the identification of an RNA profile in saliva, specific for endometriosis. This study focuses on the expression of genes involved in the control and regulation of apoptosis, cell survival, metabolism, cell adhesion and invasion, angiogenesis, inflammation, and estrogen receptor expression levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Observational study

Trials testing the same drug.

NCT07255443 — Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital · not yet recruiting
NCT07343713 — Correlation Between the Degree of Middle Ear Pressure and the Eustachian Tube Dimensions : Radiological Study · not yet recruiting
NCT07192991 — Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America · not yet recruiting
NCT07219927 — Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: · recruiting
NCT06244238 — A Study on the Relationship Between Job Satisfaction and Retention Intentions of Emergency Room Nurses · unknown

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

NCT06559852 — The Impact of Yoga on Endometriosis-Related Pain · NA · recruiting
NCT07393295 — Efficacy and Tolerability of TENS in Endometriosis-related Pain · NA · recruiting
NCT07134023 — Educational Program for the Multidisciplinary Support of Patients With Endometriosis · NA · recruiting
NCT07240883 — ENDO1000 - A UK-wide Endometriosis Research Project · recruiting
NCT06974773 — Remote Electrical Stimulation as a Long-term Intervention for Endometriosis Flare Ups · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06100471 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eurofins Genoma
Last refreshed: 20 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06100471.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing